Barret Rush1, Kali Romano2, Mohammad Ashkanani3, Robert C McDermid4, Leo Anthony Celi5. 1. Division of Critical Care Medicine, Department of Medicine, Vancouver General Hospital, University of British Columbia, Room 2438, Jim Pattison Pavilion, 2nd Floor, 855 W 12th Ave, Vancouver, British Columbia, Canada V5Z 1M9; Harvard T.H. Chan School of Public Health, Harvard University, 677 Huntington Ave, Boston, MA 02115. Electronic address: bar890@mail.harvard.edu. 2. Department of Anesthesia, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: kaliromano@gmail.com. 3. Division of Epilepsy, Department of Neurology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: ashkanani63@hotmail.com. 4. Division of Critical Care Medicine, Department of Medicine, Vancouver General Hospital, University of British Columbia, Room 2438, Jim Pattison Pavilion, 2nd Floor, 855 W 12th Ave, Vancouver, British Columbia, Canada V5Z 1M9; Department of Critical Care Medicine, Surrey Memorial Hospital, Surrey, BC, Canada. Electronic address: robmcdermid@telus.net. 5. Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: lceli@bidmc.harvard.edu.
Abstract
OBJECTIVE: There have been suggestions that patients with subarachnoid hemorrhage (SAH) have a better outcome when treated in high-volume centers. Much of the published literature on the subject is limited by an inability to control for severity of SAH. METHODS: This is a nationwide retrospective cohort analysis using the Nationwide Inpatient Sample (NIS). The NIS Subarachnoid Severity Scale was used to adjust for severity of SAH in multivariate logistic regression modeling. RESULTS: The records of 47 911 414 hospital admissions from the 2006-2011 NIS samples were examined. There were 11 607 patients who met inclusion criteria for the study. Of these, 7787 (67.0%) were treated at a high-volume center compared with 3820 (32.9%) treated at a low-volume center. Patients treated at high-volume centers compared with low-volume centers were more likely to receive endovascular aneurysm control (58.5% vs 51.2%, P=.04), be transferred from another hospital (35.4% vs 19.7%, P<.01), be treated in a teaching facility (97.3% vs 72.9%, P<.01), and have a longer length of stay (14.9 days [interquartile range 10.3-21.7] vs 13.9 days [interquartile range, 8.9-20.1], P<.01). After adjustment for all baseline covariates, including severity of SAH, treatment in a high-volume center was associated with an odds ratio for death of 0.82 (95% confidence interval, 0.72-0.95; P<.01) and a higher odds of a good functional outcome (odds ratio, 1.16; 95% confidence interval, 1.04-1.28; P<.01). CONCLUSION: After adjustment for severity of SAH, treatment in a high-volume center was associated with a lower risk of in-hospital mortality and a higher odds of a good functional outcome.
OBJECTIVE: There have been suggestions that patients with subarachnoid hemorrhage (SAH) have a better outcome when treated in high-volume centers. Much of the published literature on the subject is limited by an inability to control for severity of SAH. METHODS: This is a nationwide retrospective cohort analysis using the Nationwide Inpatient Sample (NIS). The NIS Subarachnoid Severity Scale was used to adjust for severity of SAH in multivariate logistic regression modeling. RESULTS: The records of 47 911 414 hospital admissions from the 2006-2011 NIS samples were examined. There were 11 607 patients who met inclusion criteria for the study. Of these, 7787 (67.0%) were treated at a high-volume center compared with 3820 (32.9%) treated at a low-volume center. Patients treated at high-volume centers compared with low-volume centers were more likely to receive endovascular aneurysm control (58.5% vs 51.2%, P=.04), be transferred from another hospital (35.4% vs 19.7%, P<.01), be treated in a teaching facility (97.3% vs 72.9%, P<.01), and have a longer length of stay (14.9 days [interquartile range 10.3-21.7] vs 13.9 days [interquartile range, 8.9-20.1], P<.01). After adjustment for all baseline covariates, including severity of SAH, treatment in a high-volume center was associated with an odds ratio for death of 0.82 (95% confidence interval, 0.72-0.95; P<.01) and a higher odds of a good functional outcome (odds ratio, 1.16; 95% confidence interval, 1.04-1.28; P<.01). CONCLUSION: After adjustment for severity of SAH, treatment in a high-volume center was associated with a lower risk of in-hospital mortality and a higher odds of a good functional outcome.
Authors: Joshua B Bederson; E Sander Connolly; H Hunt Batjer; Ralph G Dacey; Jacques E Dion; Michael N Diringer; John E Duldner; Robert E Harbaugh; Aman B Patel; Robert H Rosenwasser Journal: Stroke Date: 2009-01-22 Impact factor: 7.914
Authors: Tiffany R Chang; Robert G Kowalski; J Ricardo Carhuapoma; Rafael J Tamargo; Neeraj S Naval Journal: J Crit Care Date: 2015-01-10 Impact factor: 3.425
Authors: Michael N Diringer; Thomas P Bleck; J Claude Hemphill; David Menon; Lori Shutter; Paul Vespa; Nicolas Bruder; E Sander Connolly; Giuseppe Citerio; Daryl Gress; Daniel Hänggi; Brian L Hoh; Giuseppe Lanzino; Peter Le Roux; Alejandro Rabinstein; Erich Schmutzhard; Nino Stocchetti; Jose I Suarez; Miriam Treggiari; Ming-Yuan Tseng; Mervyn D I Vergouwen; Stefan Wolf; Gregory Zipfel Journal: Neurocrit Care Date: 2011-09 Impact factor: 3.210
Authors: Hieronymus D Boogaarts; Martinus J van Amerongen; Joost de Vries; Gert P Westert; André L M Verbeek; J André Grotenhuis; Ronald H M A Bartels Journal: J Neurosurg Date: 2013-10-04 Impact factor: 5.115
Authors: DeWitte T Cross; David L Tirschwell; Mary Ann Clark; Dan Tuden; Colin P Derdeyn; Christopher J Moran; Ralph G Dacey Journal: J Neurosurg Date: 2003-11 Impact factor: 5.115
Authors: Shyam Prabhakaran; Gregg C Fonarow; Eric E Smith; Li Liang; Ying Xian; Megan Neely; Eric D Peterson; Lee H Schwamm Journal: Neurosurgery Date: 2014-11 Impact factor: 4.654
Authors: Mitchell F Berman; Robert A Solomon; Stephan A Mayer; S Claiborne Johnston; Pixie P Yung Journal: Stroke Date: 2003-08-07 Impact factor: 7.914
Authors: Laura C C van Meenen; Sanne J den Hartog; Adrien E Groot; Bart J Emmer; Martin D Smeekes; Arjen Siegers; Geert Jan Kommer; Charles B L M Majoie; Yvo B W E M Roos; Adriaan C G M van Es; Diederik W Dippel; H Bart van der Worp; Hester F Lingsma; Bob Roozenbeek; Jonathan M Coutinho Journal: Eur J Neurol Date: 2021-09-23 Impact factor: 6.288
Authors: Bowen Jiang; Matthew T Bender; Bima Hasjim; Frank P K Hsu; Rafael J Tamargo; Judy Huang; Geoffrey P Colby; Alexander L Coon; Li-Mei Lin Journal: Surg Neurol Int Date: 2017-07-25
Authors: Alexander Hammer; Gholamreza Ranaie; Eduard Yakubov; Frank Erbguth; Markus Holtmannspoetter; Hans-Herbert Steiner; Hendrik Janssen Journal: Aging (Albany NY) Date: 2020-04-20 Impact factor: 5.682
Authors: Sang-Won Park; Ji Young Lee; Nam Hun Heo; James Jisu Han; Eun Chae Lee; Dong-Yong Hong; Dong-Hun Lee; Man Ryul Lee; Jae Sang Oh Journal: Front Neurol Date: 2022-08-05 Impact factor: 4.086